Search
for

    Glossary Ozempic

    Ozempic is a medication primarily used to manage type 2 diabetes by mimicking the effects of the hormone GLP-1, which helps regulate blood sugar levels. Its relevance to hair loss stems from anecdotal reports and emerging studies suggesting that weight loss associated with Ozempic may lead to temporary hair shedding in some individuals. Key distinguishing characteristics include its active ingredient, semaglutide, and its mechanism of action, which involves appetite suppression and increased insulin sensitivity. While not directly a hair loss treatment, its side effects can impact hair health in certain users.

    Research 10 of 37

    1. Skin Impacts and Tradeoffs of GLP-1 Therapy: Improved Patient-Reported Outcomes of Inflammatory Skin Disease in the Era of “Ozempic Face” Dermatology and Therapy · 2026
    2. GLP-1 e Estética: Ozempic Face, Flacidez e Recuperação Open MIND · 2026
    3. GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects Frontiers in Endocrinology · 2021 · 59 citations
    4. Semaglutide Treatment of Excessive Body Weight in Obese PCOS Patients Unresponsive to Lifestyle Programs Journal of Clinical Medicine · 2023 · 29 citations
    5. Risk of Suicide, Hair Loss, and Aspiration with GLP1-Receptor Agonists and Other Diabetic Agents: A Real-World Pharmacovigilance Study Cardiovascular Drugs and Therapy · 2024 · 25 citations
    6. Alopecia and Semaglutide: Connecting the Dots for Patient Safety Journal of Cosmetic Dermatology · 2025 · 4 citations
    7. Targeting Obesity in PCOS: A Review of Current Pharmacological Interventions and Future Directions Medicina Moderna - Modern Medicine · 2025 · 1 citations
    8. Nonscarring Alopecia in Adults Treated With GLP ‐1s: A Propensity Score Matched TriNetX Cohort Study The Laryngoscope · 2026
    9. EFLÚVIO TELÓGENO ASSOCIADO AO USO DE MEDICAMENTOS EMAGRECEDORES: MECANISMOS FISIOPATOLÓGICOS E EVIDÊNCIAS CLÍNICAS Revista Ibero-Americana de Humanidades, Ciências e Educação · 2026
    10. 0439 Temporal–phenotype signatures of alopecia associated with GLP-1–based therapies: A PRISMA-ScR scoping review Journal of Investigative Dermatology · 2026
    All research results →

    Community 3 of 4

    1. Will Pp405 be the Ozempic of bald Guys Reddit · 6 Feb 2026
    2. Wouldn’t it be funny if there already was a drug that existed which reactivated sleeping follicles? It would be our own version of Ozempic Reddit · 28 Dec 2024
    3. Finally - Big Pharma now targeting hair-loss once again! Reddit · 22 Sept 2026
    All community results →

    Learn

    — no results

    Try a deeper search in learn →